Gordon Robert - Janssen Res & Dev LLC

基本信息

浏览量：18

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 28 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Efficacy and safety of nipocalimab in adult patients with active systemic lupus erythematosus: design of a phase 2 study

Fang Liu-Walsh, Bart van Hartingsveldt,Qing Zuraw,Robert W. Hoffman,Terence Rooney,Sheng Gao,Ana Maria Bravo Perdomo,Robert Gordon,Jocelyn H. Leu,Cesar Calderon,Federico Zazzetti,Anne M. Stevens,

Lupus Science and Medicineno. Suppl 1 (2023): S59-S60

引用0浏览0引用

Efficacy and Safety of Ustekinumab in Patients With Active Systemic Lupus Erythematosus: Results of a Phase II Open-label Extension Study

Ronald F van Vollenhoven,Bevra H Hahn,George C Tsokos,Peter Lipsky,Robert M Gordon,Kaiyin Fei,Kim Hung Lo,Marc Chevrier,Shawn Rose,Pamela Berry,Zhenling Yao,Chetan S Karyekar,

JOURNAL OF RHEUMATOLOGY（2022）

引用15浏览0WOS引用

PO.6.137 Design of a phase 2, multicenter, randomized, placebo-controlled, parallel-group, double-blind study to assess the efficacy and safety of nipocalimab in adults with active systemic lupus erythematosus

T Rooney,R Gordon, G Vratsanos, C Calderon, S Gao,RW Hoffman, F Zazzetti, F Liu-Walsh, B Van Hartingsveldt, Q Zuraw,JH Leu, A Berhanu Debella

Lupus Science and Medicineno. Suppl 2 (2022)

引用0浏览0引用

SRI-4 and BICLA: How Well Do They Agree Across Trials of Active Systemic Lupus Erythematosus

Alfredo Aguirre, Mimi Kim,Kosalaram Goteti, Ying Li,Amy Kao, Nathalie Franchimont, George Kong,Catherine Barbey,Qing Zuraw,Robert Gordon, David Manner,Maria Silk,

ARTHRITIS & RHEUMATOLOGY (2022): 4049-4052

引用0浏览0引用

Phase 3, multicentre, randomised, placebo-controlled study evaluating the efficacy and safety of ustekinumab in patients with systemic lupus erythematosus

Ronald F. van Vollenhoven,Kenneth C. Kalunian,Thomas Doerner,Bevra H. Hahn,Yoshiya Tanaka,Robert M. Gordon,Cathye Shu,Kaiyin Fei,Sheng Gao,Loqmane Seridi, Patrick Gallagher,Kim Hung Lo,

ANNALS OF THE RHEUMATIC DISEASESno. 11 (2022): 1556-1563

引用19浏览0WOS引用

Efficacy and Safety of Ustekinumab in Patients with Active Systemic Lupus Erythematosus: Results Through 2 Years of an Open-Label Extension in a Phase 2 Study

Ronald F van Vollenhoven,Bevra H. Hahn,George C. Tsokos,Peter E. Lipsky,R. Gordon, K. Fei,Kim Hung Lo,Marc Chevrier,Shawn Rose,Pamela Berry,Zhenling Yao,Chetan S Karyekar,

The Journal of Rheumatology (2021)

引用12浏览0引用

Suppression Of Serum Interferon-Gamma Levels As A Potential Measure Of Response To Ustekinumab Treatment In Patients With Systemic Lupus Erythematosus

Matteo Cesaroni,Loqmane Seridi,Matthew J Loza,Jessica Schreiter,Kristen Sweet,Carol Franks,Keying Ma,Ashley Orillion,Kim Campbell,Robert Gordon,Patrick Branigan,Peter Lipsky,

ARTHRITIS & RHEUMATOLOGY（2021）

引用16浏览0WOS引用

Interdisciplinary Safety Evaluation for Learning and Decision-Making

Greg Ball,Barbara A. Hendrickson, Amy L. Freedman,Robert Gordon,Brenda Crowe, Melissa F. Veenhuizen,James Buchanan

Ther Innov Regul Sci（2021）

引用2浏览0WOS引用

Maintenance of Efficacy and Safety of Ustekinumab Through One Year in a Phase II Multicenter, Prospective, Randomized, Double‐Blind, Placebo‐Controlled Crossover Trial of Patients With Active Systemic Lupus Erythematosus

Ronald F. Vollenhoven,Bevra H. Hahn,George C. Tsokos,Peter Lipsky,Kaiyin Fei,Robert M. Gordon, Irene Gregan,Kim Hung Lo,Marc Chevrier,Shawn Rose

Arthritis & Rheumatology（2020）

引用75浏览0引用

Maintenance of efficacy and safety of ustekinumab through 1 year in a randomized phase II trial of patients with active systemic lupus erythematosus

Ronald F van Vollenhoven,Bevra H Hahn,George C Tsokos,Peter Lipsky,Kaiyin Fei,Robert M Gordon, Irene Gregan,Kim Hung Lo,Marc Chevrier,Shawn Rose

ARTHRITIS & RHEUMATOLOGY（2020）

引用67浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn